Solutions
You will receive an email with a link to the webinar
Examine the details of a University of Miami study
Umbilical cord-derived mesenchymal stem cell infusions may reduce the risk of death and quicken recovery time for COVID-19 patients suffering the most severe conditions, according to a recent study.
Join Dr. Camillo Ricordi, the study’s senior author, as he reviews the data and the potential for stem cells to be used more broadly to treat COVID-19 and similar respiratory infections. Highlights from the study:
The stem cell infusions also clearly inhibited the ‘cytokine storm,’ associated with severe COVID-19. A single umbilical cord contains enough mesenchymal stem cells when expanded to provide therapeutic doses for over 10,000 patients. Register now to learn all the implications of this important study.
Can't make the live webinar?
Register now to receive a link to the recording and slides.
Recorded Oct 23, 2018
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
Dr. Ricordi is well-known for inventing the machine that made it possible to isolate large numbers of islet cells (insulin-producing cells) from the human pancreas and for performing the first series of successful clinical islet transplants that reversed diabetes after implantation of donor purified islets into the liver of recipients with diabetes. He has also developed innovative strategies to reverse rejection of transplanted cells and organs. Dr. Ricordi was the senior author of the study presented in this webinar.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.